Pneumonitis
18
3
3
9
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
16.7%
3 terminated out of 18 trials
75.0%
-11.5% vs benchmark
11%
2 trials in Phase 3/4
44%
4 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (18)
Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therapy
Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis
Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis
GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)
Tocilizumab for Patients With Cancer and COVID-19 Disease
A Study on the Combination Therapy of Eravacycline for Treating Carbapenem-Resistant Acinetobacter Baumannii Pneumonia
Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis
Avoiding Neuromuscular Blockers to Reduce Complications
Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19)
Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP
Study of Collagen IV and XIX in Bronchoalveolar Lavage, Pulmonary Aspiration and Bronchial Biopsies
Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease
Everolimus Related Pneumonitis in MBC
Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia
Accurate Classification System for Patients With COVID-19 Pneumonitis
Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication
Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients
Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer